Insider track record Other Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by RIGGS RORY B. Insider active across 4 companies, notably Royalty Pharma plc. Aggregated, 62 disclosures have been logged. Split: 0 buy · 17 sells. Total volume traded: €110.3m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 2 April 2025 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Declarations 62 total
131,512 shares @ US$132.00 90.2% of flow Common Stock SEC:0000950170-25-049648:0
● Chief Executive Officer · Executives · 31 Dec 2024 · Cibus, Inc. 1,388,084 shares Class B Common Stock SEC:0001615594-25-000004:0
215 shares @ US$83.52 0.1% of flow Common Stock SEC:0000950170-25-001440:0
14,189 shares Common Stock SEC:0000950170-24-114785:0
246 shares @ US$73.17 0.1% of flow Common Stock SEC:0000950170-24-111766:0
◆ Chief Executive Officer · Executives · 18 Sept 2024 · Cibus, Inc. 250,000 shares @ US$4.00 49.1% of flow Class A Common Stock SEC:0000950170-24-108504:0
262 shares @ US$68.49 0.1% of flow Common Stock SEC:0000950170-24-080986:0
1,567 shares Common Stock SEC:0000950170-24-077468:0
◆ Chief Executive Officer · Executives · 11 Jun 2024 · Cibus, Inc. 98,040 shares @ US$10.20 50.9% of flow Class A Common Stock SEC:0000950170-24-073319:0
260 shares @ US$69.20 0.1% of flow Common Stock SEC:0000950170-24-040165:0
20,000 shares @ US$18.56 1.9% of flow Common Stock SEC:0000950170-24-035358:0
300,000 shares 0Class A Ordinary Shares SEC:0001802768-24-000014:0
235,200 shares @ US$28.5165 5.6% of flow Class A Ordinary Shares SEC:0001802768-24-000002:0
● Chief Executive Officer · Executives · 29 Dec 2023 · Cibus, Inc. 1,505,967 shares 0Class B Common Stock SEC:0000899243-24-000057:0
251 shares @ US$71.62 0.1% of flow Common Stock SEC:0000950170-24-001305:0
● Chief Executive Officer · Executives · 27 Sept 2023 · Cibus, Inc. 39,476 shares 0Class A Common Stock SEC:0000950170-23-070459:0
475,590 shares 0Class A Ordinary Shares SEC:0001802768-23-000030:0
345 shares @ US$52.09 0.1% of flow Common Stock SEC:0001209191-23-051140:0
279 shares @ US$63.32 0.1% of flow Common Stock SEC:0001209191-23-041097:0
7,747 shares 0Class A Ordinary Shares SEC:0001209191-23-039694:0
◆ Chief Executive Officer · Executives · 31 May 2023 · Cibus, Inc. 848,662 shares Class A Common Stock SEC:0000899243-23-014329:0
1,750,000 shares @ US$32.82 48.7% of flow Class A Ordinary Shares SEC:0001209191-23-031614:0
300,000 shares 0Class A Ordinary Shares SEC:0001209191-23-029216:0
313 shares @ US$54.15 0.1% of flow Common Stock SEC:0001209191-23-022791:0
9,926 shares @ US$36.95 0.3% of flow Class A Ordinary Shares SEC:0001209191-23-021649:0
25 of 62 declarations
Load more (37 remaining) About RIGGS RORY B Rory B Riggs is an executive at Royalty Pharma plc.